ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 2 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2 | 0.0% | 3,081 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | 0.0% | 3,081 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | -100.0% | 3,081 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +66.7% | 3,081 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 3,081 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -76.5% | 3,081 | -6.1% | 0.00% | – |
| Q4 2021 | $17,000 | +750.0% | 3,281 | +1540.5% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 4,387,590 | $46,772,000 | 15.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,091,749 | $43,618,000 | 5.75% |
| GRIFFIN ASSET MANAGEMENT, INC. | 1,439,613 | $15,346,000 | 2.36% |
| Selkirk Management LLC | 348,805 | $3,718,000 | 1.18% |
| Chicago Capital, LLC | 1,966,891 | $20,967,000 | 1.08% |
| Trellus Management Company, LLC | 46,834 | $499,000 | 0.51% |
| Cannell & Co. | 1,118,439 | $11,923,000 | 0.44% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $1,652,000 | 0.36% |
| Belpointe Asset Management LLC | 419,406 | $3,982,000 | 0.27% |
| TCI Wealth Advisors, Inc. | 55,586 | $593,000 | 0.23% |